1 Center for Human Genetics, Faculty of Medicine, University of Kinshasa, Democratic Republic of Congo, DRC.
2 Division of Gynecology Obstetrics, Center for Sickle Cell Anemia, Kinshasa, DRC.
3 Division of Pediatrics, Hospital University, Faculty of Medicine, University of Kinshasa, DRC.
4 Division of Internal Medicine, Service of Immuno hemato Rheumatology, Hospital University, Faculty of Medicine, University of Kinshasa, DRC.
5 Division of Gynecology Obstetrics, Hospital University, Faculty of Medicine, University of Kinshasa, DRC.
| This is an Open Access article distributed
under the terms of the Creative Commons Attribution License
(https://creativecommons.org/licenses/by-nc/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
to determine the beneficial role of Fetal Hemoglobin (FHb) and
alpha-thal on fetal and maternal morbidity during pregnancy in sickle
Patients and Methods
|Table 1. General Characteristics of Sickle Cell Pregnancy by Genotype.|
|Table 2. The biological variables of the pregnant.|
|Figure 1. Evolution of VOC and worsening of anemia during pregnancy.|
|Table 3. Frequencies of maternal and fetal complications.|
|Figure 2. Distribution of parasitic and bacterial infections during pregnancy.|